Science Explorer Back to mapMap
Discussion
Researcher · Tulane University · United States

Radhika R. Pochampally

Radhika R. Pochampally publishes mostly in Molecular Biology, Cancer Research and Genetics, on topics such as Mesenchymal stem cell research, MicroRNA in disease regulation and Cancer Cells and Metastasis.

ORCID 0000-0002-4263-0364 OpenAlex
World rank
#101,011
of 7,710,434 ranked researchers
Rank in United States
#38,636
of 1,627,098
Works
79
Citations
8.3k
Citations per work
105.1
h-index
41
i10-index 55Top 6.7% in Molecular Biology
Radhika R. Pochampally

What does Radhika R. Pochampally research?

Radhika R. Pochampally's work is mostly in Biochemistry, Genetics and Molecular Biology (41%), Medicine (36%).

Life Sciences: 33 works · 41.2% of their workBiochemistry, Genetics and Molecular Biology: 33 works · 41.2% of their workMolecular Biology: 21 works · 27.0% of their workCancer Research: 11 works · 14.2% of their workHealth Sciences: 28 works · 35.8% of their workMedicine: 28 works · 35.8% of their workGenetics: 10 works · 12.7% of their workOncology: 10 works · 12.3% of their workPulmonary and Respiratory Medicine: 5 works · 5.9% of their workSurgery: 4 works · 4.9% of their workEverything else: 18 works · 23.0% of their workTHEIR WORKRadhika R.Pochampally79works
Life Sciences41%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology3341.2%
    1. Medicine2835.8%
  3. Everything else1823.0%
  1. 1Molecular Biology27% of their works
  2. 2Cancer Research14% of their works
  3. 3Genetics13% of their works
  4. 4Oncology12% of their works
  5. 5Pulmonary and Respiratory Medicine6% of their works
  6. 6Surgery5% of their works

Research topics

Which keywords describe Radhika R. Pochampally's research?

The keywords of their largest research topics: Cancer, Biogenesis, Biomarkers, Mesenchymal Stem Cells, Multipotent, Cancer Stem Cells, Gene Expression and MicroRNA.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Cancer363 topics
  2. Biogenesis292 topics
  3. Biomarkers292 topics
  4. Mesenchymal Stem Cells251 topic
  5. Multipotent251 topic
  6. Cancer Stem Cells171 topic
  7. Gene Expression171 topic
  8. MicroRNA171 topic
  9. Tumor Metastasis171 topic
  10. Gene Therapy162 topics
  11. Exosomes121 topic
  12. Extracellular Vesicles121 topic
  13. RNA Interference101 topic
  14. siRNA Delivery101 topic
  15. Decellularization91 topic
  16. Extracellular Matrix91 topic
  17. Long Noncoding RNAs71 topic
  18. RNA Regulation71 topic
  19. Bacterial Therapy61 topic
  20. Tumor Targeting61 topic

Where does Radhika R. Pochampally work?

Radhika R. Pochampally's main affiliation in the publication record is Tulane University, United States.

How many publications and citations does Radhika R. Pochampally have?

OpenAlex counts 79 works and 8,299 citations for Radhika R. Pochampally, an h-index of 41, ranking #101,011 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Radhika R. Pochampally. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.